Newsfiscal.ai
MindWalk Announces Agreement with Teva Australia to Support Defined Antibody-Discovery Workflows
· Published
Article summary
MindWalk Holdings Corp. has entered into a multi-year agreement with Teva Pharmaceuticals Australia Pty Ltd to deploy its AI-powered biological context layer for antibody discovery.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…